When you see the light at the end of a tunnel, sometimes it's a moving train. The piece below comes from a writer at Scripps Institute and appears in Xconomy. It addresses the need for very good communication and incentive alignment between the pharma industry and academic institutions in order to properly manage broad research alliances.
How To Keep Academic/Big Pharma Alliances from Going off the Rails.
The benefits from this type of hands on management are minimized disagreements, maximized revenue opportunities, and enhanced funding and collaborative opportunties, especially for the academic participants. It's the best way to keep on the tracks.
Posted by Bruce Lehr November 30th 2010.
Comments